Alnylam Pharmaceuticals, Inc.
Methods of Treating Transthyretin (TTR) Mediated Amyloidosis

Abstract:

Disclosed herein are methods for reducing or arresting an increase in a Neuropathy Impairment Score (NIS) or a modified NIS (mNIS+7) in a human subject by administering an effective amount of a transthyretin (TTR)-inhibiting composition.